As an outpatient facility, we work with Central IRBs and sponsor-preferred IRBs to ensure fast turnaround, transparency, and close collaboration with sponsors and CROs—all while meeting the highest ethical and study standards.
Just 10 minutes from JFK and near LaGuardia, we’re within reach of Connecticut and New Jersey. With access to top medical professionals and institutions, we’re equipped to support nearly any study or patient need.
Our diverse team speaks multiple languages, helping us communicate effectively with a wide range of participants and improve enrollment from underrepresented groups.
We work directly with sponsors and CROs, using Central IRBs for fast trial turnaround. Our top-down management and quick budgeting cut red tape and simplify collaboration.
With nearly 20 years in business, we’re one of the Tri-State area’s leading neuroscience research facilities. Our experienced team of MDs, PAs, NPs, RNs, LPNs, and CRAs work closely with local clinicians to deliver efficient, expert results.
Located on Long Island’s South Shore near the Queens-Nassau border, we’re within 30 minutes of 5 million people. We engage underrepresented communities, providing access to clinical trials and reaching often untapped patient populations.
Five Towns Neuroscience Research is one of the premiere non-university based neuroscience research facilities in the tri-state area providing a combined >50 years of clinical trials research experience.
A clinical study is carefully designed to test the effects of a medication, medical treatment, or device on a group of volunteers. Clinical studies are an important step in making new medications available. They measure the drug's ability to treat a condition, its safety and its possible side effects.
Some trials involve new medications not available to the general public. Other studies focus on existing medications which are being evaluated for their effectiveness compared to other medications.
Medications are tested in a laboratory setting.
'First in man' studies with 40-100 healthy volunteers to determine safety and side effects.
Drug is given to a small group of patients with the condition being treated.
Final stage involving hundreds of patient volunteers before FDA approval.
Post-marketing studies to monitor long-term safety and drug interactions.
People with the condition being studied as well as healthy people can volunteer to participate in a clinical trial. The FDA has very strict requirements that specify which studies involve healthy volunteers and which studies involve patients with the condition being studied.
Each study has specific requirements such as age, gender, or medical/psychiatric condition for participants. Initially, a research assistant will ask you basic information about your current condition and medications during a brief interview by phone or in person that will allow them to find out if you are a good candidate to participate in a clinical trial.
If you qualify based on the phone screen, you will be scheduled for an appointment to speak to the doctor or nurse practitioner. During the clinical appointment the study will be discussed with you in detail and you will be given the opportunity to decide if you want to participate in the study.
When you arrive at Five Towns Neuroscience Research, you will meet with the doctor and/or the nurse practitioner who are part of the research team conducting the trial. Before any person can participate in a clinical trial, they must first consent to participate by signing an Informed Consent Form.
The research team is trained in medical and mental health research. They will explain everything about the trial, what to expect, and answer any questions or concerns you might have. When you make the appointment, they will tell you what to expect in the first visit.
Key Benefits:
In some cases the U.S. Food and Drug Administration has already approved the medication for other uses in the United States and the trial is being conducted to determine the effectiveness in treating your condition.
The government has strict guidelines and safeguards to protect people who choose to participate in clinical trials. Every clinical trial in the U.S. must be approved and monitored by an Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits.
An IRB is an independent committee of physicians, statisticians, community advocates, and others that ensures that a clinical trial is ethical and the rights of study participants are protected. All institutions that conduct or support biomedical research involving people must, by federal regulation, have an IRB that initially approves and periodically reviews the research.
Confidentiality: All information collected during your participation in the trial is held confidential. A unique code is assigned to you that will be used on all information related to your care.
Right to Withdraw: At any point, if you so desire, you can withdraw from the study. That is your right and you can exercise it at any time without penalty.
Informed consent is the process of learning the key facts about a clinical trial before you decide whether or not to participate.
Key facts include:
Remember: Informed consent is more than signing a form. It is a process that continues through the study. You should feel free to ask the research team questions before, during, and after the study. Informed consent continues as long as you are in the study.
If you are considering joining a clinical trial, the research staff will give you informed consent documents that include the details about the study. Since joining a clinical trial is an important decision, you should ask the research team any questions you may have about the study and the consent forms before you make a decision.